278 related articles for article (PubMed ID: 36807239)
1. Is repeat sentinel lymph node biopsy possible for surgical axillary staging among patients with ipsilateral breast tumor recurrence?
Lu X; He M; Yu L; Gou Z
Cancer; 2023 May; 129(10):1492-1501. PubMed ID: 36807239
[TBL] [Abstract][Full Text] [Related]
2. Low Risk of Development of a Regional Recurrence After an Unsuccessful Repeat Sentinel Lymph Node Biopsy in Patients with Ipsilateral Breast Tumor Recurrence.
Poodt IGM; Walstra CJEF; Vugts G; Maaskant-Braat AJG; Voogd AC; Schipper RJ; Nieuwenhuijzen GAP;
Ann Surg Oncol; 2019 Aug; 26(8):2417-2427. PubMed ID: 30850903
[TBL] [Abstract][Full Text] [Related]
3. Added value of repeat sentinel lymph node biopsy in FDG-PET/CT node-negative patients with ipsilateral breast cancer recurrence.
Haarsma R; van Loevezijn AA; Donswijk ML; Scholten AN; Vrancken Peeters MTFD; van Duijnhoven FH
Breast Cancer Res Treat; 2022 Aug; 194(3):617-627. PubMed ID: 35727380
[TBL] [Abstract][Full Text] [Related]
4. Repeat Sentinel Lymph Node Biopsy for Ipsilateral Breast Tumor Recurrence: A Systematic Review of the Results and Impact on Prognosis.
Poodt IGM; Vugts G; Schipper RJ; Nieuwenhuijzen GAP
Ann Surg Oncol; 2018 May; 25(5):1329-1339. PubMed ID: 29468606
[TBL] [Abstract][Full Text] [Related]
5. Risk of Regional Recurrence After Negative Repeat Sentinel Lymph Node Biopsy in Patients with Ipsilateral Breast Tumor Recurrence.
Poodt IGM; Vugts G; Maaskant-Braat AJG; Schipper RJ; Voogd AC; Nieuwenhuijzen GAP;
Ann Surg Oncol; 2018 May; 25(5):1312-1321. PubMed ID: 29497910
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis.
Fan YJ; Li JC; Zhu DM; Zhu HL; Zhao Y; Zhu XB; Wu G; Bai TT
BMC Surg; 2023 Jul; 23(1):209. PubMed ID: 37495945
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study.
Zheng Q; Luo H; Xia W; Lu Q; Jiang K; Hong R; Xu F; Wang S
Breast Cancer Res Treat; 2022 Dec; 196(3):613-622. PubMed ID: 36207619
[TBL] [Abstract][Full Text] [Related]
8. The evolution of the sentinel node procedure in the treatment of breast cancer.
Tvedskov TF
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer.
Sávolt Á; Cserni G; Lázár G; Maráz R; Kelemen P; Kovács E; Győrffy B; Udvarhelyi N; Vörös A; Ormándi K; Mátrai Z
Eur J Surg Oncol; 2019 Oct; 45(10):1835-1838. PubMed ID: 31126680
[TBL] [Abstract][Full Text] [Related]
10. Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes.
Bonneau C; Hequet D; Estevez JP; Pouget N; Rouzier R
Eur J Surg Oncol; 2015 Aug; 41(8):998-1004. PubMed ID: 25986854
[TBL] [Abstract][Full Text] [Related]
11. Axillary treatment for operable primary breast cancer.
Bromham N; Schmidt-Hansen M; Astin M; Hasler E; Reed MW
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004561. PubMed ID: 28052186
[TBL] [Abstract][Full Text] [Related]
12. Technical feasibility of sentinel lymph node biopsy in patients with ipsilateral breast tumor recurrence and previous axillary surgery.
Matsumoto A; Jinno H; Nakamura T; Saito J; Takahashi M; Hayashida T; Kameyama K; Kitagawa Y
Int J Surg; 2015 Oct; 22():28-31. PubMed ID: 26278666
[TBL] [Abstract][Full Text] [Related]
13. Survival After Sentinel Lymph Node Biopsy Compared with Axillary Lymph Node Dissection for Female Patients with T3-4c Breast Cancer.
Li P; Yang C; Zhang J; Chen Y; Zhang X; Liang M; Huang N; Chen Y; Wang K
Oncologist; 2023 Aug; 28(8):e591-e599. PubMed ID: 36929946
[TBL] [Abstract][Full Text] [Related]
14. Comparing Early-Stage Breast Cancer Patients with Sentinel Lymph Node Metastasis with and without Completion Axillary Lymph Node Dissection: A Systematic Review and Meta-Analysis.
Heiranizadeh N; Rafiei Shahamabadi M; Dehghan HR; Jafari-Nedooshan J; Kargar S; Zare M; Amooei A; Shiryazdi SM; Broomand MA; Moravej MT; Sadri Z
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2561-2571. PubMed ID: 36037108
[TBL] [Abstract][Full Text] [Related]
15. Axilla lymph node dissection can be safely omitted in patients with 1-2 positive sentinel nodes receiving mastectomy: a large multi-institutional study and a systemic meta-analysis.
Gao W; Lu S; Zeng Y; Chen X; Shen K
Breast Cancer Res Treat; 2022 Nov; 196(1):129-141. PubMed ID: 36076127
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer.
Simons JM; van Nijnatten TJA; van der Pol CC; van Diest PJ; Jager A; van Klaveren D; Kam BLR; Lobbes MBI; de Boer M; Verhoef C; Sars PRA; Heijmans HJ; van Haaren ERM; Vles WJ; Contant CME; Menke-Pluijmers MBE; Smit LHM; Kelder W; Boskamp M; Koppert LB; Luiten EJT; Smidt ML
JAMA Surg; 2022 Nov; 157(11):991-999. PubMed ID: 36069889
[TBL] [Abstract][Full Text] [Related]
17. Altered lymphatic drainage patterns in re-operative sentinel lymph node biopsy for ipsilateral breast tumor recurrence.
Sato A; Sakai T; Iwase T; Kano F; Kimura K; Ogiya A; Koizumi M; Tanabe M; Horii R; Akiyama F; Ueno T; Ohno S
Radiat Oncol; 2019 Sep; 14(1):159. PubMed ID: 31477153
[TBL] [Abstract][Full Text] [Related]
18. Oncological Safety of Skipping Axillary Lymph Node Dissection in Patients with Clinical N0, Sentinel Node-Positive Breast Cancer Undergoing Total Mastectomy.
Chun JW; Kang E; Kim HK; Lee HB; Moon HG; Lee JW; Han W
Ann Surg Oncol; 2024 May; 31(5):3168-3176. PubMed ID: 38368292
[TBL] [Abstract][Full Text] [Related]
19. Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical Trial.
Canavese G; Bruzzi P; Catturich A; Tomei D; Carli F; Garrone E; Spinaci S; Lacopo F; Tinterri C; Dozin B
Ann Surg Oncol; 2016 Aug; 23(8):2494-500. PubMed ID: 26975739
[TBL] [Abstract][Full Text] [Related]
20. Patterns of completion axillary dissection for patients with cT1-2N0 breast cancer undergoing total mastectomy with positive sentinel lymph nodes.
Schwieger L; Postlewait LM; Subhedar PD; Geng F; Liu Y; Gillespie T; Arciero CA
J Surg Oncol; 2024 Mar; 129(3):468-480. PubMed ID: 37955191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
